Changing systems for measuring activated clotting times: Impact on the clinical practice of heparin anticoagulation during cardiac surgery

We demonstrated that the introduction of the Actalyke® ACT system significantly altered our clinical practice by increasing the heparin dose required to exceed our target ACT during CPB. Prospective study to determine the effect of Actalyke® ACT system monitoring on hemostasis after cardiac surgery is merited.